Related Experiment Video
Updated: May 1, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Chinese thyroid imaging reporting and data system with redefined marked hypoechogenicity for thyroid malignancy risk
Yingxue Bai1, Mingxin Yu1, Size Wu1
1Department of Ultrasound, The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan Province, China.
A modified Chinese Thyroid Imaging Reporting and Data System (C-TIRADS) with a redefined marked hypoechogenicity criterion improves thyroid nodule malignancy risk assessment. This enhanced C-TIRADS offers better accuracy and aligns risk stratification with expected probabilities.
Area of Science:
- Radiology and Imaging
- Oncology
- Endocrinology
Background:
- Distinguishing benign from malignant thyroid nodules via ultrasound presents diagnostic challenges.
- Current thyroid nodule classification systems require refinement for improved malignancy risk stratification.
Purpose of the Study:
- To evaluate the diagnostic performance of a modified Chinese Thyroid Imaging Reporting and Data System (C-TIRADS).
- To assess the impact of a redefined criterion for marked hypoechogenicity in stratifying thyroid nodule malignancy risk.
Main Methods:
- Retrospective analysis of 1,219 patients with 1,721 thyroid nodules undergoing ultrasound and subsequent biopsy/treatment.
- Interobserver agreement for marked hypoechogenicity was assessed using kappa statistics.
- Diagnostic performance (sensitivity, specificity, accuracy, AUC) of modified C-TIRADS, classical C-TIRADS, and K-TIRADS was compared using histopathology as the reference standard.
Main Results:
- Redefining marked hypoechogenicity improved interobserver agreement (kappa from 0.652 to 0.722) and significantly enhanced sensitivity (74.5% vs. 15.1%) and accuracy (86.8% vs. 70.8%).
- Modified C-TIRADS demonstrated superior accuracy (90.2%) and AUC (0.908) compared to classical C-TIRADS (88.2%, 0.870) and K-TIRADS (81.3%, 0.857).
- Malignancy rates for modified C-TIRADS categories were 12.0% (4a), 60.6% (4b), 85.8% (4c), and 93.3% (5).
Conclusions:
- The modified C-TIRADS, with its redefined marked hypoechogenicity criterion, significantly improves diagnostic performance for thyroid nodule malignancy risk stratification.
- This enhanced system provides risk assessments that more closely align with expected probabilities, aiding clinical decision-making.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Hyperthyroidism I: Introduction
Hyperthyroidism II: Pathophysiology
Goiter

